# PGL4001 Versus Placebo in Uterine Myomas

> **NCT00755755** · PHASE3 · COMPLETED · sponsor: **PregLem SA** · enrollment: 241 (actual)

## Conditions studied

- Uterine Myomas

## Interventions

- **DRUG:** PGL4001 (ulipristal) and iron
- **DRUG:** PGL4001 matching placebo and iron
- **DRUG:** PGL4001 (ulipristal) and iron

## Key facts

- **NCT ID:** NCT00755755
- **Lead sponsor:** PregLem SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2010-03
- **Final completion:** 2010-08
- **Target enrollment:** 241 (ACTUAL)
- **Last updated:** 2012-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00755755

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00755755, "PGL4001 Versus Placebo in Uterine Myomas". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00755755. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*